Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of BCD-180 in Patients With Active Axial Spondyloarthritis

NCT06333210 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT06333210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of BCD-180 in Patients With Active Axial Spondyloarthritis
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 25, 2023
Completion date
February 29, 2028
Enrollment
421 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis